Using mouse models and transcriptional studies of patients’ lesions, we demonstrated that cytotoxicity induced by CD8 T cells drives immunopathology in cutaneous leishmaniasis [6–10]. The gene discussed is CD8A; the disease is cutaneous leishmaniasis.